A Chinese medicine-based herbal formula developed in Taiwan called Taiwan Chingguan Erhau (清冠二號), or NRICM102, could reduce the mortality rate of COVID-19 cases who experience severe symptoms by 50 percent, National Research Institute of Chinese Medicine (NRICM) director Su Yi-chang (蘇奕彰) said.
Su talked about the treatment on Sunday at the Taipei Traditional Chinese Medicine International Forum, saying that following the success of Taiwan Chingguan Yihau (清冠一號), or NRICM101, the institute is applying for patents and trademarks for the new formulation.
In 2020, permission was granted to export Taiwan Chingguan Yihau, and it has been sold in more than 50 countries with positive responses from overseas, Su said.
Photo: Tsai Si-pei, Taipei Times
Taiwan Chingguan Yihau received emergency use authorization in May last year from the Ministry of Health and Welfare, which allowed it to be manufactured and used for clinical treatment in Taiwan.
Eight pharmaceutical companies have authorization to manufacture the formula.
Taiwan Chingguan Erhau is a modification of its predecessor, which includes indigowoad root, heartleaf houttuynia herb and scutellaria root, among others, Su said.
Ingredients “helpful in fighting viruses” and “regulating the immune system” remain in Taiwan Chingguan Erhau, while stronger substances that “help bolster health maintenance” were substituted for those with modest effects, he added.
Clinical trials of Taiwan Chingguan Yihau were conducted from May to August last year in 15 hospitals including the Tri-Service General Hospital, Taipei Hospital and Taoyuan General Hospital.
Results showed that the chance of people with COVID-19 developing severe symptoms was reduced by 80 percent if they were using the formula, Su said.
Over the same period, more than 100 cases with severe symptoms received Taiwan Chingguan Erhau in clinical trials, with results suggesting a 50 percent drop in mortality rate within 30 days, he said.
Asking pharmaceutical companies to target only COVID-19 cases with severe symptoms is impractical as the pandemic wanes, Su said, adding that the institute plans to test Taiwan Chingguan Erhau’s usefulness against other severe lung diseases.
The formula’s effectiveness in treating chronic obstructive pulmonary disease, cardiac and pulmonary arrest, and pulmonary embolism are being assessed, he said.
Su also said that unlike Western medicines that target one disease, a Chinese medical formula can usually treat many diseases.
Taking Chinese medicine is unlikely to produce side effects or develop resistance the same way drugs or antibiotics do, he said.
Su said that the institute plans to approach companies that are interested in manufacturing Taiwan Chingguan Erhau and follow the procedures for launching new medical treatments in Taiwan.
SECURITY: Starlink owner Elon Musk has taken pro-Beijing positions, and allowing pro-China companies to control Taiwan’s critical infrastructure is risky, a legislator said Starlink was reluctant to offer services in Taiwan because of the nation’s extremely high penetration rates in 4G and 5G services, the Ministry of Digital Affairs said yesterday. The ministry made the comments at a meeting of the legislature’s Transportation Committee, which reviewed amendments to Article 36 of the Telecommunications Management Act (電信管理法). Article 36 bans foreigners from holding more than 49 percent of shares in public telecommunications networks, while shares foreigners directly and indirectly hold are also capped at 60 percent of the total, unless specified otherwise by law. The amendments, sponsored by Chinese Nationalist Party (KMT) Legislator Ko
The eastern extension of the Taipei MRT Red Line could begin operations as early as late June, the Taipei Department of Rapid Transit Systems said yesterday. Taipei Rapid Transit Corp said it is considering offering one month of free rides on the new section to mark its opening. Construction progress on the 1.4km extension, which is to run from the current terminal Xiangshan Station to a new eastern terminal, Guangci/Fengtian Temple Station, was 90.6 percent complete by the end of last month, the department said in a report to the Taipei City Council's Transportation Committee. While construction began in October 2016 with an
NON-RED SUPPLY: Boosting the nation’s drone industry is becoming increasingly urgent as China’s UAV dominance could become an issue in a crisis, an analyst said Taiwan’s drone exports to Europe grew 41.7-fold from 2024 to last year, with demand from Ukraine’s fight against Russian aggression the most likely driver of growth, a study showed. The Institute for Democracy, Society and Emerging Technology (DSET) in a statement on Wednesday said it found that many of Taiwan’s uncrewed aerial vehicle (UAV) sales were from Poland and the Czech Republic. These countries likely transferred the drones to Ukraine to aid it in its fight against the Russian invasion that started in 2022, it said. Despite the gains, Taiwan is not the dominant drone exporter to these markets, ranking second and fourth
The New Taipei City Art Museum this weekend plans to celebrate its first anniversary with a two-day extravaganza featuring live concerts and a large-scale synchronized fireworks and drone display, the New Taipei City Cultural Affairs Department said. The two-day celebrations are to take place in the museum’s outdoor park, with markets and live performances by singers including Ann Bai (白安), Bii (畢書盡) and the Cosmos People (宇宙人), the department said. The highlight on both evenings would be the "Echoes of Light" show, an aerial spectacle combining fireworks and drone performances designed around the concept of "dual stages in the sky," it
RSS